- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
CME Group Shares Sold by Sarasin & Partners LLP
Institutional ownership remains mixed as analysts have mixed views on the stock
Mar. 22, 2026 at 10:18am
Got story updates? Submit your updates here. ›
Sarasin & Partners LLP reduced its stake in CME Group Inc. (NASDAQ:CME) by 2.9% in the 4th quarter, according to the company's recent SEC filing. The fund owned 1,092,937 shares of the financial services provider's stock after selling 32,308 shares during the period. CME Group accounts for approximately 3.1% of Sarasin & Partners LLP's investment portfolio.
Why it matters
CME Group operates some of the world's largest derivatives exchanges, and institutional investor activity in the stock can provide insights into market sentiment around the company. The mixed analyst views and insider selling activity may also impact how investors perceive the stock.
The details
Sarasin & Partners LLP reduced its stake in CME Group by 2.9% in the fourth quarter, selling 32,308 shares. The fund now owns 1,092,937 shares, or approximately 0.30% of CME Group. Analyst actions have been mixed, with some firms raising price targets and ratings while others remain cautious. Insider selling activity, such as the recent sale by General Counsel Jonathan L. Marcus, has also been highlighted by data aggregators, which can weigh on sentiment.
- Sarasin & Partners LLP reduced its stake in the fourth quarter of 2025.
- General Counsel Jonathan L. Marcus sold 3,291 shares on March 17, 2026.
The players
Sarasin & Partners LLP
An investment management firm that reduced its stake in CME Group in the fourth quarter.
Jonathan L. Marcus
The General Counsel of CME Group who sold 3,291 shares in March 2026.
The takeaway
The mixed institutional activity and analyst sentiment around CME Group highlights the nuanced views on the stock, with some positive signals like the dividend increase balanced by insider selling and cautious analyst outlooks. Investors will likely continue to monitor the company's performance and market positioning as it navigates the evolving financial services landscape.
Chicago top stories
Chicago events
Mar. 22, 2026
Hamilton (Chicago)Mar. 22, 2026
Chicago Blackhawks vs. Nashville PredatorsMar. 22, 2026
Madama Butterfly



